Apo J/clusterin expression and secretion: evidence for 15-deoxy-Δ(12,14)-PGJ(2)-dependent mechanism

Damien Gates1, Kiera Dollin, Roisin Connolly

  • 1Nutrition and Metabolism Group, Centre for Public Health, Queen's University Belfast, Pathology Building, RVH, Grosvenor Road, BT12 6BJ, Belfast, Northern Ireland, UK.

Insights

Cyclooxygenase-2 (Cox-2) upregulates clusterin expression via 15-deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ(2)), heat shock factor 1 (HSF-1), and peroxisome proliferator activated receptor (PPAR)γ. However, clusterin does not mediate Cox-2

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Cyclooxygenase-2 (Cox-2) and clusterin are implicated in inflammatory resolution.
  • Both molecules have been reported to inhibit nuclear factor-kappa B (NF-κB) signaling.
  • Investigating the interplay between Cox-2 and clusterin in NF-κB signaling is crucial for understanding inflammatory processes.

Purpose of the Study:

  • To investigate the interdependence between Cox-2 and clusterin in a rat pheochromocytoma (PC12) cell model.
  • To determine how Cox-2 overexpression affects clusterin expression and NF-κB signaling.
  • To elucidate the molecular mechanisms underlying Cox-2-mediated clusterin induction.

Main Methods:

  • Utilized a PC12 cell culture model with Cox-2 overexpression (PCXII) and control cells (PCMT).
  • Employed gene expression and immunoblot analysis to quantify clusterin levels.
  • Investigated the role of 15-deoxy-Δ(12,14)-prostaglandin J(2) (15d-PGJ(2)), heat shock factor 1 (HSF-1), and peroxisome proliferator activated receptor (PPAR)γ in clusterin regulation.

Main Results:

  • Cox-2 overexpression led to increased intracellular and secreted clusterin levels in PCXII cells.
  • Clusterin expression was induced by 15d-PGJ(2) in control cells and inhibited by Cox inhibition in PCXII cells.
  • Cox-2/15d-PGJ(2)-dependent clusterin upregulation was mediated by HSF-1 and PPARγ activation.
  • PCXII cells showed reduced TNF-α-induced ICAM-1 expression, but NF-κB signaling components (IκB phosphorylation/degradation) were similar to controls.
  • Despite reduced NF-κB transcriptional activity in PCXII cells, clusterin knockdown did not restore it, indicating clusterin is not the mediator of this inhibition.

Conclusions:

  • Cox-2 induces clusterin expression in a 15d-PGJ(2)-dependent manner, involving HSF-1 and PPARγ.
  • The study does not support a model where clusterin mediates the inhibition of NF-κB signaling by Cox-2/15d-PGJ(2).
  • Further research is needed to fully understand the role of clusterin in Cox-2-related inflammatory pathways.

Related Concept Videos